Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Sections
Personal tools
Log in
 
You are here: Home › Protocols › BRSCW Applicant: Morre - NOX Technologies Inc. (2009)

BRSCW Applicant: Morre - NOX Technologies Inc. (2009)

324
Morre, D. James — NOX Technologies
tNOX, ENOX, ENOX2, NXOB826, NX034
Other
Proteomics
Breast and Gynecologic Cancers Research

Evaluation using NOX Technologies ECTO-NOX blot diagnostic 2-D gel electrophoretic cancer detection system in combination with a sandwich ELISA of our derivation


To obtain preliminary indications of utility for serum detection of breast and ovarian cancer.
sandwich ELISA

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.


Announcement